Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Strong Initial Assay Results for its Fall 2024 Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Psychemedics Corp PMDI

Healthcare Medical Care
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair... see more

Recent & Breaking News (OTCPK:PMDI)

Psychemedics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Declares Quarterly Cash Dividend

GlobeNewswire March 21, 2023

Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

GlobeNewswire November 9, 2022

Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

GlobeNewswire August 9, 2022

Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.'s Retirement after More than 20 Years of Dedicated Service

GlobeNewswire June 9, 2022

Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend

GlobeNewswire May 10, 2022

Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 29, 2022

Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Connick From His Director Role

GlobeNewswire March 22, 2022

Psychemedics Corporation Declares Cash Dividend

GlobeNewswire December 10, 2021

Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021

GlobeNewswire November 12, 2021

Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results

GlobeNewswire August 10, 2021

Psychemedics Corporation Reports First Quarter 2021 Financial Results

GlobeNewswire May 10, 2021

Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 23, 2021

Robyn C. Davis Joins Psychemedics Board of Directors

GlobeNewswire March 17, 2021

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

GlobeNewswire January 26, 2021

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

GlobeNewswire December 17, 2020

Psychemedics Announces Third Quarter Results

GlobeNewswire November 9, 2020

Psychemedics Announces Second Quarter Results

GlobeNewswire August 12, 2020

Psychemedics Announces First Quarter Results

GlobeNewswire May 13, 2020

Psychemedics Announces a "Vaping Panel" to Detect and Deter the Use of Marijuana, CBD and Nicotine

GlobeNewswire May 5, 2020

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

GlobeNewswire April 29, 2020